Transition Therapeutics (TTHI) Doubles on Purchase by OPKO

Transition Therapeutics Inc. TTHI shares hurtled 110.9% higher to $1.48, on announcing the signing of a definitive agreement under which OPKO Health will acquire Transition Therapeutics, a clinical stage biotechnology company. Share volume was 1.4 million, triumphing over an all-day average of 52,000